| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 646 |
| 1 | RANITIDINE | 551 |
| 2 | METHOTREXATE SODIUM | 532 |
| 3 | ASPIRIN | 489 |
| 4 | ETANERCEPT | 485 |
| 5 | METHOTREXATE | 473 |
| 6 | ASPIRIN 325 MG | 459 |
| 7 | ASPIRIN 81 MG | 459 |
| 8 | INFLIXIMAB | 450 |
| 9 | RANITIDINE HYDROCHLORIDE | 391 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FRUQUINTINIB | 381 | 0.0967 |
| 1 | REGORAFENIB | 344 | 0.0296 |
| 2 | PANITUMUMAB | 278 | 0.0173 |
| 3 | INFLIXIMAB-DYYB | 38 | 0.0110 |
| 4 | LEVOLEUCOVORIN INJECTION | 33 | 0.0107 |
| 5 | DAPRODUSTAT | 21 | 0.0105 |
| 6 | ERGOCALCIFEROL | 289 | 0.0097 |
| 7 | IRINOTECAN HYDROCHLORIDE | 122 | 0.0093 |
| 8 | LEVOLEUCOVORIN | 35 | 0.0092 |
| 9 | GOLIMUMAB | 98 | 0.0078 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 972 |
| 1 | Corticosteroid [EPC] | 944 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 932 |
| 3 | Platelet Aggregation Inhibitor [EPC] | 507 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 505 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 474 |
| 6 | Proton Pump Inhibitor [EPC] | 464 |
| 7 | Angiotensin 2 Receptor Blocker [EPC] | 435 |
| 8 | Loop Diuretic [EPC] | 429 |
| 9 | Benzodiazepine [EPC] | 383 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 25 | 0.0110 |
| 1 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 2 | Epidermal Growth Factor Receptor Antagonist [EPC] | 329 | 0.0070 |
| 3 | Serotonin-4 Receptor Agonist [EPC] | 2 | 0.0030 |
| 4 | SLAMF7-directed Immunostimulatory Antibody [EPC] | 13 | 0.0025 |
| 5 | Tyrosine Kinase 2 Inhibitor [EPC] | 7 | 0.0024 |
| 6 | Non-Standardized Fungal Allergenic Extract [EPC] | 5 | 0.0023 |
| 7 | Chloride Channel Activator [EPC] | 22 | 0.0023 |
| 8 | CCR5 Co-receptor Antagonist [EPC] | 5 | 0.0022 |
| 9 | Integrin Receptor Antagonist [EPC] | 181 | 0.0021 |